Bionovo   Report issue

For profit Phase 2 Phase 3
Founded: Emeryville California United States (2002)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2006
NCT00454441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Bionovo Inc.